College of Science and Mathematics
9 achievements
Bush, J., Kitaura, H., Ma, Y., Teitelbaum, S., Ross, F., & Smith, J.
(2012).
Comparative proteomic analysis of a cytosolic fraction from b3 integrin-deficient cells.
Cancer Genomics & Proteomics. 9(1),
1-13.
|
| Amirikia, K., Mills, P., Bush, J., & Newman, L.
(2011).
Higher population-based incidence rates of triple-negative breast cancer among young African-American women.
Cancer. 117(12),
2747-2753.
|
| Morshedian, S., Contreras, C., Hamud, W., Dhakal, B., Khanal, B., & Bush, J.
(2011).
Anti-angiogenic effects of zoledronic acid on osteotropic breast cancer cells.
Presented at
Experimental Biology Meeting, Washington, DC. |
| Hale, J., Yamamoto, F., & Bush, J.
(2010).
Proteomic evaluation of pesticide-resistant breast cancer cell lines.
Presented at
Experimental Biology Meeting, Anaheim, CA. |
| Morshedian, S., Contreras, C., & Bush, J.
(2010).
Zoledronic acid (Zometa®) preferentially induces cell death in a bone-metastasizing breast cancer cell line.
Presented at
Special Conference of the American Association of Cancer Research, San Diego, CA. |
| Morshedian, S., Contreras, C., & Bush, J.
(2010).
Zoledronic acid increases anti-angiogenic factors in an osteotropic breast cancer cell line.
Presented at
Experimental Biology Meeting, Anaheim, CA. |
| Piestrup, N., Liu, J., & Bush, J.
(2010).
Development of Protocols for Enrichment of Specific Endocytic Vesicles Involved in β3 Integrin Recycling in a Cell Culture Model.
Presented at
31st Annual Central California Research Symposium. |
| Carillo, B., Villalvazo, A., Nitido, A., Ritchey, J., & Bush, J.
(2009).
Multi-drug resistant ovarian cancer cells are less susceptible to orlistat-induced cell death.
Presented at
2nd Cancer Health Disparities–Minorities in Cancer Research, Carefree, AZ. |
| Chu, R., Miller, S., & Bush, J.
(2009).
Secretome Analyses from Staged Pancreatic Cancer Cell Lines.
Presented at
5th US Human Proteome Organization (USHUPO), San Diego, CA. |
